← Open Payments lookup

VICKI FRYE: Open Payments

NPI 1942271093 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,271 in 108 payments from 23 companies in 2025. Trend: 2023 $1,658 · 2024 $2,096 · 2025 $2,271

Food & beverage: $2,231Long term medical supply or device loan: $40
CompanyPaymentsAmount
Novo Nordisk Inc22$435
ABBVIE INC.16$344
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$260
Abbott Laboratories8$165
AstraZeneca Pharmaceuticals LP2$137
Axsome Therapeutics, Inc.1$123
PFIZER INC.7$108
Bayer Healthcare Pharmaceuticals Inc.5$96
Otsuka America Pharmaceutical, Inc.4$81
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$78

Products named: VRAYLAR, CAPLYTA, Rybelsus, Ozempic, FREESTYLE LIBRE 3, FARXIGA, Auvelity, Kerendia.

Industry payments across TN — which companies pay providers there.